1. Home
  2. CDXC vs CYH Comparison

CDXC vs CYH Comparison

Compare CDXC & CYH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDXC
  • CYH
  • Stock Information
  • Founded
  • CDXC 1999
  • CYH 1985
  • Country
  • CDXC United States
  • CYH United States
  • Employees
  • CDXC N/A
  • CYH N/A
  • Industry
  • CDXC Medicinal Chemicals and Botanical Products
  • CYH Hospital/Nursing Management
  • Sector
  • CDXC Health Care
  • CYH Health Care
  • Exchange
  • CDXC Nasdaq
  • CYH Nasdaq
  • Market Cap
  • CDXC 449.5M
  • CYH 440.4M
  • IPO Year
  • CDXC N/A
  • CYH 1991
  • Fundamental
  • Price
  • CDXC $5.70
  • CYH $3.36
  • Analyst Decision
  • CDXC Strong Buy
  • CYH Hold
  • Analyst Count
  • CDXC 2
  • CYH 6
  • Target Price
  • CDXC $8.00
  • CYH $4.40
  • AVG Volume (30 Days)
  • CDXC 341.1K
  • CYH 1.9M
  • Earning Date
  • CDXC 03-05-2025
  • CYH 02-18-2025
  • Dividend Yield
  • CDXC N/A
  • CYH N/A
  • EPS Growth
  • CDXC N/A
  • CYH N/A
  • EPS
  • CDXC 0.02
  • CYH N/A
  • Revenue
  • CDXC $91,668,000.00
  • CYH $12,551,000,000.00
  • Revenue This Year
  • CDXC $18.64
  • CYH $1.16
  • Revenue Next Year
  • CDXC $20.72
  • CYH $1.18
  • P/E Ratio
  • CDXC $280.54
  • CYH N/A
  • Revenue Growth
  • CDXC 9.95
  • CYH 0.81
  • 52 Week Low
  • CDXC $1.46
  • CYH $2.51
  • 52 Week High
  • CDXC $7.97
  • CYH $6.29
  • Technical
  • Relative Strength Index (RSI)
  • CDXC 47.71
  • CYH 45.86
  • Support Level
  • CDXC $5.60
  • CYH $3.20
  • Resistance Level
  • CDXC $6.08
  • CYH $3.39
  • Average True Range (ATR)
  • CDXC 0.27
  • CYH 0.16
  • MACD
  • CDXC -0.01
  • CYH 0.02
  • Stochastic Oscillator
  • CDXC 28.75
  • CYH 47.14

About CDXC ChromaDex Corporation

ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.

About CYH Community Health Systems Inc.

Community Health Systems Inc is a publicly owned hospital operator in the United States. The company also owns four home health agencies and provides management and consulting services to independent hospitals. The firm derives revenue through a broad range of general and specialized hospital healthcare services and outpatient services.

Share on Social Networks: